Sam Stone

Samuel S. Stone

Samuel S. Stone
+1 617 570 1624

Sam Stone is an associate in Goodwin’s Business Law Department and a member of its Technology Companies group. Mr. Stone's practice includes the strategic development, management and protection of intellectual property portfolios, as well as IP diligence in mergers, acquisitions, IPOs, sales, and investment transactions.

Mr. Stone’s portfolio development practice focuses on domestic and international patents and opinion work concerning clearance, patentability, infringement and validity. He has experience prosecuting patents on behalf of clients in the areas of lidar technology, software (including artificial intelligence and machine learning tools, cyber-security platforms, and device firmware), applications of AI in the life science and agricultural technology sectors, biosensors, integrated circuits, computer hardware, and electronic devices.


Representative clients and matters include:

Patent Portfolio Development

  • Represented a leading manufacturer of lidar technology in the development of its global patent portfolio and strategic enforcement of its IP rights against competitors.
  • Represented a software start-up in the development of its patent portfolio and enforcement of its IP rights during a seven-year period when the company’s valuation increased from less than $100 million to more than $6 billion. The company’s patents focused on automated machine learning, data analytics, and artificial intelligence tools.
  • Developed patent portfolios for clients in the life science and agricultural technology sectors relating to the use of artificial intelligence in the discovery of drug candidates; directed evolution of microbes for therapeutics, materials, and food; and detection, monitoring, and management of health conditions.
  • Counseled early-stage start-ups on issues of potential patent infringement as a barrier to market entry.
  • Mined clients’ patent portfolios for claims suitable for assertion against competitors, and performed infringement analyses on the competitors’ products.
  • Prepared technical analysis for written opinions relating to invalidity and noninfringement of a competitor's patents on microprocessor technology.


  • Represented Bain Capital Tech Opportunities as lead investor in BioCatch’s $145 million Series C round.
  • Represented Xeraya Capital in connection with its investment in a portfolio company.
  • Represented DST Global VI, LP in its investment in Root Stockholdings, Inc., a car insurance company that uses technology in smartphones to measure driving behavior to identify safe drivers.
  • Represented Carbon Black in its $1.6 billion IPO and its subsequent $2.1 billion acquisition by VMware.
  • Represented Credit Suisse in underwriting Everbridge Inc. in its $90 million IPO. Everbridge is a unified critical communications platform trusted by corporations and communities of all sizes.

Professional Activities

Mr. Stone has served as a judge for the MIT $100K Entrepreneurship Launch Competition. He is also a member of the Boston Patent Law Association.

Professional Experience

Prior to joining Goodwin, Mr. Stone was an associate in the Electrical and Computing Technologies Group at Wolf, Greenfield & Sacks, P.C. in Boston.




Harvard Law School

Master of Science2007

University of Illinois at Urbana-Champaign


Virginia Tech



  • Massachusetts
  • U.S. Patent and Trademark Office (USPTO)

Recognition & Awards

Mr. Stone was named a Massachusetts Rising Star by Super Lawyers every year from 2018 to 2021, and was recognized as One to Watch in 2023 by Best Lawyers for his excellence in intellectual property matters. As a student, Mr. Stone was the recipient of the U.S. National Science Foundation Graduate Research Fellowship and a member of the Tau Beta Pi National Engineering Honor Society.


Sam has co-authored many research papers and articles, including those published in the Journal of Parallel and Distributed Computing and the International Symposium on Microarchitecture (MICRO). Three of Sam’s publications have been cited more than 150 times.